Biofrontera (BFRI) Set to Announce Earnings on Wednesday

Biofrontera (NASDAQ:BFRI) will announce its earnings results after the market closes on Wednesday, May 15th. Analysts expect the company to announce earnings of ($1.63) per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

Biofrontera (NASDAQ:BFRI) last posted its earnings results on Friday, March 15th. The company reported ($2.33) EPS for the quarter. The firm had revenue of $10.60 million during the quarter. Biofrontera had a negative net margin of 59.09% and a negative return on equity of 344.98%. On average, analysts expect Biofrontera to post $-4 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Biofrontera Price Performance

BFRI opened at $1.60 on Wednesday. The business has a fifty day simple moving average of $1.53 and a 200 day simple moving average of $2.24. Biofrontera has a 1 year low of $0.61 and a 1 year high of $13.42. The company has a market capitalization of $8.14 million, a PE ratio of -0.10 and a beta of 0.65.

Biofrontera Company Profile

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.